Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.
2.

Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.

Farmer JR, Foldvari Z, Ujhazi B, De Ravin SS, Chen K, Bleesing JJH, Schuetz C, Al-Herz W, Abraham RS, Joshi AY, Costa-Carvalho BT, Buchbinder D, Booth C, Reiff A, Ferguson PJ, Aghamohammadi A, Abolhassani H, Puck JM, Adeli M, Cancrini C, Palma P, Bertaina A, Locatelli F, Di Matteo G, Geha RS, Kanariou MG, Lycopoulou L, Tzanoudaki M, Sleasman JW, Parikh S, Pinero G, Fischer BM, Dbaibo G, Unal E, Patiroglu T, Karakukcu M, Al-Saad KK, Dilley MA, Pai SY, Dutmer CM, Gelfand EW, Geier CB, Eibl MM, Wolf HM, Henderson LA, Hazen MM, Bonfim C, Wolska-Kuśnierz B, Butte MJ, Hernandez JD, Nicholas SK, Stepensky P, Chandrakasan S, Miano M, Westermann-Clark E, Goda V, Kriván G, Holland SM, Fadugba O, Henrickson SE, Ozen A, Karakoc-Aydiner E, Baris S, Kiykim A, Bredius R, Hoeger B, Boztug K, Pashchenko O, Neven B, Moshous D, Villartay JP, Bousfiha AA, Hill HR, Notarangelo LD, Walter JE.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1970-1985.e4. doi: 10.1016/j.jaip.2019.02.038. Epub 2019 Mar 12.

3.

Translation and validation of the Transition Readiness Assessment Questionnaire (TRAQ).

Anelli CG, Len CA, Terreri MTRA, Russo GCS, Reiff AO.

J Pediatr (Rio J). 2019 Mar - Apr;95(2):180-187. doi: 10.1016/j.jped.2017.12.013. Epub 2018 Feb 16.

4.

Age and fecal microbial strain-specific differences in patients with spondyloarthritis.

Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL Jr, Danila MI, Spencer CH, Punaro MG, Schikler K, Reiff A, Kumar R, Cron RQ, Morrow CD, Lefkowitz EJ.

Arthritis Res Ther. 2018 Jan 30;20(1):14. doi: 10.1186/s13075-018-1510-6.

5.

Challenges in transitioning adolescents and young adults with rheumatologic diseases to adult Care in a Developing Country - the Brazilian experience.

Anelli CG, Amorim ALM, Osaku FM, Terreri MT, Len CA, Reiff A.

Pediatr Rheumatol Online J. 2017 May 30;15(1):47. doi: 10.1186/s12969-017-0176-y.

6.

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, Abud-Mendoza C, Reiff A, Alexeeva E, Rubio-Pérez N, Keltsev V, Kingsbury DJ, Del Rocio Maldonado Velázquez M, Nikishina I, Silverman ED, Joos R, Smolewska E, Bandeira M, Minden K, van Royen-Kerkhof A, Emminger W, Foeldvari I, Lauwerys BR, Sztajnbok F, Gilmer KE, Xu Z, Leu JH, Kim L, Lamberth SL, Loza MJ, Lovell DJ, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Ann Rheum Dis. 2018 Jan;77(1):21-29. doi: 10.1136/annrheumdis-2016-210456. Epub 2017 May 15.

7.

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.

Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative.

Arthritis Rheumatol. 2016 Oct;68(10):2514-26. doi: 10.1002/art.39729.

8.

Transition of Care and Health-Related Outcomes in Pediatric-Onset Systemic Lupus Erythematosus.

Felsenstein S, Reiff AO, Ramanathan A.

Arthritis Care Res (Hoboken). 2015 Nov;67(11):1521-8. doi: 10.1002/acr.22611.

9.

Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus.

Brunner HI, Silva CA, Reiff A, Higgins GC, Imundo L, Williams CB, Wallace CA, Aikawa NE, Nelson S, Klein-Gitelman MS, Rose SR.

Arthritis Rheumatol. 2015 May;67(5):1377-85. doi: 10.1002/art.39024.

10.

Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.

Chang CY, Meyer RM, Reiff AO.

Arthritis Care Res (Hoboken). 2015 May;67(5):658-66. doi: 10.1002/acr.22477.

11.

The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever.

Hashkes PJ, Spalding SJ, Hajj-Ali R, Giannini EH, Johnson A, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright D, Lovell DJ, Huang B.

Biomed Res Int. 2014;2014:854842. doi: 10.1155/2014/854842. Epub 2014 May 15.

12.

Racial health disparities among special health care needs children with mental disorders: do medical homes cater to their needs?

Park C, Tan X, Patel IB, Reiff A, Balkrishnan R, Chang J.

J Prim Care Community Health. 2014 Oct;5(4):253-62. doi: 10.1177/2150131914539814. Epub 2014 Jun 25.

PMID:
24970879
13.

Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.

Stern S, Clemente G, Reiff A, Ramos MP, Marzan KA, Terreri MT.

J Clin Rheumatol. 2014 Jun;20(4):183-8. doi: 10.1097/RHU.0000000000000106.

PMID:
24847743
14.

Rheumatic Disease Clinics of North America. Pediatric rheumatology. Preface.

Reiff A.

Rheum Dis Clin North Am. 2013 Nov;39(4):xvii-xviii. doi: 10.1016/j.rdc.2013.07.001. Epub 2013 Jul 27. No abstract available.

PMID:
24182863
15.

Rheumatic inflammatory eye diseases of childhood.

Reiff A, Kadayifcilar S, Özen S.

Rheum Dis Clin North Am. 2013 Nov;39(4):801-32. doi: 10.1016/j.rdc.2013.05.005. Epub 2013 Jul 13. Review.

PMID:
24182856
16.
17.

T lymphocyte abnormalities in juvenile systemic sclerosis patients.

Reiff A, Weinberg KI, Triche T, Masinsin B, Mahadeo KM, Lin CH, Brown D, Parkman R.

Clin Immunol. 2013 Oct;149(1):146-55. doi: 10.1016/j.clim.2013.07.005. Epub 2013 Aug 7.

PMID:
23994768
18.

Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.

Lovell DJ, Giannini EH, Reiff AO, Kimura Y, Li S, Hashkes PJ, Wallace CA, Onel KB, Foell D, Wu R, Biedermann S, Hamilton JD, Radin AR.

Arthritis Rheum. 2013 Sep;65(9):2486-96. doi: 10.1002/art.38042.

19.

Pediatric chronic nonbacterial osteomyelitis.

Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, Sundel RP.

Pediatrics. 2012 Nov;130(5):e1190-7. doi: 10.1542/peds.2011-3788. Epub 2012 Oct 15.

PMID:
23071213
20.

Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.

Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ.

Ann Intern Med. 2012 Oct 16;157(8):533-41. doi: 10.7326/0003-4819-157-8-201210160-00003. Erratum in: Ann Intern Med. 2014 Feb 18;160(4):291-2.

PMID:
23070486
21.

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions.

Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O'Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA; ARChiVe Investigators Network.

J Rheumatol. 2012 Oct;39(10):2012-20. doi: 10.3899/jrheum.120299. Epub 2012 Aug 1.

PMID:
22859342
22.

Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis.

Uribe AG, Huber AM, Kim S, O'Neil KM, Wahezi DM, Abramson L, Baszis K, Benseler SM, Bowyer SL, Campillo S, Chira P, Hersh AO, Higgins GC, Eberhard A, Ede K, Imundo LF, Jung L, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Li SC, Lovell DJ, Mason T, McCurdy D, Muscal E, Nassi L, Rabinovich E, Reiff A, Rosenkranz M, Schikler KN, Singer NG, Spalding S, Stevens AM, Cabral DA; ARegistry for Children with Vasculitis e-entry (ARChiVe) Network.

J Rheumatol. 2012 Aug;39(8):1687-97. Epub 2012 May 15.

PMID:
22589257
23.

Pediatric rheumatic disease in the intensive care unit: lessons learned from 15 years of experience in a tertiary care pediatric hospital.

Radhakrishna SM, Reiff AO, Marzan KA, Azen C, Khemani RG, Rubin S, Menteer J, Brown DE, Shaham B.

Pediatr Crit Care Med. 2012 May;13(3):e181-6. doi: 10.1097/PCC.0b013e318238955c.

PMID:
22561277
24.

Acanthamoeba meningoencephalitis presenting as neuropsychiatric lupus in a pediatric patient.

Castillo RD, Garza JX, Shamszadeh M, Reiff AO, Marzan KA.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):272-6. Epub 2012 Apr 13.

PMID:
22409906
25.

High dose infliximab in the treatment of refractory uveitis: does dose matter?

Sukumaran S, Marzan K, Shaham B, Reiff A.

ISRN Rheumatol. 2012;2012:765380. doi: 10.5402/2012/765380. Epub 2012 Jan 5.

26.

Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe).

Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, Abramson L, Baszis K, Benseler S, Bowyer S, Campillo S, Chira P, Hersh AO, Higgins G, Eberhard A, Ede K, Imundo L, Jung L, Kim S, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Lovell DJ, Mason T, McCurdy D, Nanda K, Nassi L, O'Neil KM, Rabinovich E, Ramsey SE, Reiff A, Rosenkranz M, Schikler K, Stevens A, Wahezi D, Cabral DA; ARChiVe Investigators Network.

J Rheumatol. 2012 May;39(5):1088-94. doi: 10.3899/jrheum.111030. Epub 2012 Feb 15.

PMID:
22337238
27.

Scleroderma-like skin changes not involving the hand in a prepubertal male with type I diabetes mellitus: A case report.

Pitukcheewanont P, Bali B, Somanunt S, Reiff A.

Dermatoendocrinol. 2011 Oct;3(4):230-2. doi: 10.4161/derm.3.4.14614. Epub 2011 Oct 1.

28.
29.

Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase.

Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, Quismorio FP Jr, Reiff A, Myones BL, Kaufman KM, McCurdy D, Harley JB, Silverman E, Kimberly RP, Vyse TJ, Gaffney PM, Moser KL, Klein-Gitelman M, Wagner-Weiner L, Langefeld CD, Armstrong DL, Zidovetzki R.

Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):E59-67. doi: 10.1073/pnas.1113251108. Epub 2011 Dec 27.

30.

Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus.

Brunner HI, Mina R, Pilkington C, Beresford MW, Reiff A, Levy DM, Tucker LB, Eberhard BA, Ravelli A, Schanberg LE, Saad-Magalhaes C, Higgins GC, Onel K, Singer NG, von Scheven E, Itert L, Klein-Gitelman MS, Punaro M, Ying J, Giannini EH.

Arthritis Care Res (Hoboken). 2011 Sep;63(9):1213-23. doi: 10.1002/acr.20507.

31.

Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis.

Reiff A, Shaham B, Weinberg KI, Crooks GM, Parkman R.

J Clin Immunol. 2011 Aug;31(4):615-22. doi: 10.1007/s10875-011-9533-7. Epub 2011 May 4.

PMID:
21541793
32.

Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.

Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, Higgins G, Gottlieb B, Chon Y, Zhang N, Baumgartner SW.

Arthritis Rheum. 2010 Nov;62(11):3259-64. doi: 10.1002/art.27682.

33.

Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.

Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, Dewitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D, Woodward A; ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network.

Arthritis Rheum. 2009 Nov;60(11):3413-24. doi: 10.1002/art.24876.

34.

B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.

Hong SD, Reiff A, Yang HT, Migone TS, Ward CD, Marzan K, Shaham B, Phei WC, Garza J, Bernstein B, Stohl W.

Arthritis Rheum. 2009 Nov;60(11):3400-9. doi: 10.1002/art.24902.

35.

Study of thymic size and function in children and adolescents with treatment refractory systemic sclerosis eligible for immunoablative therapy.

Reiff A, Krogstad P, Moore S, Shaham B, Parkman R, Kitchen C, Weinberg K.

Clin Immunol. 2009 Dec;133(3):295-302. doi: 10.1016/j.clim.2009.08.010. Epub 2009 Sep 29.

PMID:
19793681
36.

Experience with multiple stent implantations in primary antiphospholipid syndrome in childhood: a case report.

Bakkaloglu SA, Keefer MS, Schroeder S, Stanley P, Harrell DS, Reiff A.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4):664-7.

PMID:
19772804
37.

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.

Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, Higgins G, Gottlieb B, Singer NG, Chon Y, Lin SL, Baumgartner SW; Pediatric Rheumatology Collaborative Study Group.

Arthritis Rheum. 2009 Sep;60(9):2794-804. doi: 10.1002/art.24777.

38.

Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.

Reiff A.

Curr Rheumatol Rep. 2009 Jul;11(3):226-32. Review.

PMID:
19604468
39.

Identification of new SLE-associated genes with a two-step Bayesian study design.

Armstrong DL, Reiff A, Myones BL, Quismorio FP Jr, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, Ojwang JO, Kaufman KM, Kelly JA, Merrill JT, Harley JB, Bae SC, Vyse TJ, Gilkeson GS, Gaffney PM, Moser KL, Putterman C, Edberg JC, Brown EE, Ziegler J, Langefeld CD, Zidovetzki R, Jacob CO.

Genes Immun. 2009 Jul;10(5):446-56. doi: 10.1038/gene.2009.38. Epub 2009 May 14.

40.

Relationship between health-related quality of life and SLE activity and damage in children over time.

Moorthy LN, Peterson MG, Hassett AL, Baratelli M, Chalom EC, Hashkes PJ, Hong S, Reiff A, Lehman TJ.

Lupus. 2009 Jun;18(7):622-9. doi: 10.1177/0961203308101718.

PMID:
19433463
41.

High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups.

Namjou B, Sestak AL, Armstrong DL, Zidovetzki R, Kelly JA, Jacob N, Ciobanu V, Kaufman KM, Ojwang JO, Ziegler J, Quismorio FP Jr, Reiff A, Myones BL, Guthridge JM, Nath SK, Bruner GR, Mehrian-Shai R, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Putterman C, Bae SC, Kim YJ, Petri M, Reveille JD, Vyse TJ, Gilkeson GS, Kamen DL, Alarcón-Riquelme ME, Gaffney PM, Moser KL, Merrill JT, Scofield RH, James JA, Langefeld CD, Harley JB, Jacob CO.

Arthritis Rheum. 2009 Apr;60(4):1085-95. doi: 10.1002/art.24387.

42.

Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus.

Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, Zhou XJ, Thomas JA, Reiff A, Myones BL, Ojwang JO, Kaufman KM, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, Ziegler J, Kelly JA, Merrill JT, Harley JB, Ramsey-Goldman R, Vila LM, Bae SC, Vyse TJ, Gilkeson GS, Gaffney PM, Moser KL, Langefeld CD, Zidovetzki R, Mohan C.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6256-61. doi: 10.1073/pnas.0901181106. Epub 2009 Mar 27.

43.

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

Ilowite N, Porras O, Reiff A, Rudge S, Punaro M, Martin A, Allen R, Harville T, Sun YN, Bevirt T, Aras G, Appleton B.

Clin Rheumatol. 2009 Feb;28(2):129-37. doi: 10.1007/s10067-008-0995-9. Epub 2008 Sep 3.

PMID:
18766426
44.

Adalimumab in juvenile rheumatoid arthritis/juvenile idiopathic arthritis.

Marzan KA, Reiff AO.

Expert Rev Clin Immunol. 2008 Sep;4(5):549-58. doi: 10.1586/1744666X.4.5.549.

PMID:
20476957
45.

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A; Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials Organisation.

N Engl J Med. 2008 Aug 21;359(8):810-20. doi: 10.1056/NEJMoa0706290.

46.

Childhood quality of life in the changing landscape of pediatric rheumatology.

Reiff A.

J Pediatr (Rio J). 2008 Jul-Aug;84(4):285-8. doi: 10.2223/JPED.1808. No abstract available.

47.

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH; Pediatric Rheumatology Collaborative Study Group.

Arthritis Rheum. 2008 May;58(5):1496-504. doi: 10.1002/art.23427.

48.

Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform.

Jacob CO, Reiff A, Armstrong DL, Myones BL, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Solomon A, Zidovetzki R.

Arthritis Rheum. 2007 Dec;56(12):4164-73.

49.

Ocular complications of childhood rheumatic diseases: uveitis.

Reiff A.

Curr Rheumatol Rep. 2006 Dec;8(6):459-68. Review.

PMID:
17152145
50.

Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study.

Flatø B, Hoffmann-Vold AM, Reiff A, Førre Ø, Lien G, Vinje O.

Arthritis Rheum. 2006 Nov;54(11):3573-82.

Supplemental Content

Support Center